ISIN | LU1819586188 |
---|---|
Valorennummer | |
Bloomberg Global ID | |
Fondsname | Bellevue Sustainable Healthcare I2 |
Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fondsanbieter | Bellevue Asset Management AG |
Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare sector taking account of sustainability criteria. The fund can also invest in companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of “healthcare sector”, the healthcare sector includes companies from the areas of pharmaceuticals, medical technology, biotechnology and related sectors. |
Besonderheiten |
Aktueller Preis * | 187.04 EUR | 05.09.2024 |
---|---|---|
Vorheriger Preis * | 189.26 EUR | 04.09.2024 |
52 Wochen Hoch * | 192.01 EUR | 30.08.2024 |
52 Wochen Tief * | 164.15 EUR | 27.10.2023 |
NAV * | 187.04 EUR | 05.09.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 114'442'534 | |
Anteilsklassevermögen *** | ||
Trading Information SIX |
YTD-Performance | +9.21% |
29.12.2023 - 05.09.2024
29.12.2023 05.09.2024 |
---|---|---|
YTD-Performance (in CHF) | +10.36% |
29.12.2023 - 05.09.2024
29.12.2023 05.09.2024 |
1 Monat | +7.05% |
05.08.2024 - 05.09.2024
05.08.2024 05.09.2024 |
3 Monate | +5.02% |
05.06.2024 - 05.09.2024
05.06.2024 05.09.2024 |
6 Monate | +7.12% |
05.03.2024 - 05.09.2024
05.03.2024 05.09.2024 |
1 Jahr | +7.40% |
05.09.2023 - 05.09.2024
05.09.2023 05.09.2024 |
2 Jahre | +2.21% |
06.09.2022 - 05.09.2024
06.09.2022 05.09.2024 |
3 Jahre | -7.59% |
07.09.2021 - 05.09.2024
07.09.2021 05.09.2024 |
5 Jahre | -2.37% |
15.06.2021 - 05.09.2024
15.06.2021 05.09.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Vertex Pharmaceuticals Inc | 3.42% | |
---|---|---|
Regeneron Pharmaceuticals Inc | 3.31% | |
Intuitive Surgical Inc | 3.25% | |
Insulet Corp | 3.17% | |
Eli Lilly and Co | 3.09% | |
IQVIA Holdings Inc | 2.93% | |
UCB SA | 2.81% | |
Biomarin Pharmaceutical Inc | 2.78% | |
Boston Scientific Corp | 2.76% | |
Alcon Inc | 2.74% | |
Letzte Daten-Aktualisierung | 31.07.2024 |
TER | 1.40% |
---|---|
Datum TER | 29.01.2021 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | 1.35% |
SRRI ***
|
|
Datum SRRI *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |